Hypofractionated carbon‐ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study

This phase II study's aim was to confirm the efficacy and safety of hypofractionated carbon‐ion radiotherapy in patients with stage I peripheral nonsmall cell lung cancer (NSCLC). The study encompassed 37 patients with histologically proven peripheral stage I NSCLC in the period June 2010‐March...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Med
Autors principals: Saitoh, Jun‐ichi, Shirai, Katsuyuki, Mizukami, Tatsuji, Abe, Takanori, Ebara, Takeshi, Ohno, Tatsuya, Minato, Koichi, Saito, Ryusei, Yamada, Masanobu, Nakano, Takashi
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Clinical Cancer Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6825999/
https://ncbi.nlm.nih.gov/pubmed/31532584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2561
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars